Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Oncogene|November 11, 2009
Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11qM Fischer, T Bauer, A Oberthür, et al.Klinische Padiatrie|August 31, 2001
Traditional and emerging molecular markers in neuroblastoma prognosis: the good, the bad and the uglyC Poremba, B Hero, H G Goertz, et al.European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE)R Erttmann, T Tafese, F Berthold, et al.Journal of Musculoskeletal & Neuronal Interactions|September 10, 2016
Early vibration assisted physiotherapy in toddlers with cerebral palsy - a randomized controlled pilot trialC Stark, P Herkenrath, H Hollmann, et al.Medical and Pediatric Oncology|December 7, 2000
Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomasC Poremba, B Hero, B Heine, et al.Cell Death & Disease|April 13, 2013
Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastomaH Kocak, S Ackermann, B Hero, et al.Bone Marrow Transplantation|December 12, 2002
High-dose chemotherapy with autologous stem cell rescue in children with nephroblastomaB Kremens, B Gruhn, T Klingebiel, et al.Cancer Research|February 11, 1998
A lack of neuroblastoma in Down syndrome: a study from 11 European countriesD Satgé, A J Sasco, N L Carlsen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HRF Berthold, A Faldum, A Ernst, et al.Pageof 5